To assess the efficacy and safety of pf-06650833, pf-06651600, and tofacitinib alone and in combination in participants with active rheumatoid arthritis with an inadequate response to methotrexate

Condition:   Rheumatoid Arthritis Interventions:   Drug: PF-06650833;   Drug: PF-06651600;   Drug: Tofacitinib Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials